Conclusion KDZOS can adjust the blood lipid metabolism in hyperlipoproteinemia rats and restrain fattydeposition in liver.
结论：KDZOS能调节实验性高脂蛋白血症大鼠的血脂代谢，抑制肝脏脂肪沉积。
2
In fact, interleukin-1 in this scenario can induce fat deposition in the hepatocytes which is one of the characteristics on non-alcoholic fatty liver disease.
事实上，白细胞介素- 1在这种情况下可以诱导肝细胞脂肪沉积，这是非酒精性脂肪性肝病的一个特征。
3
Lobules of liver in the rats of model group was disorder with a pile of deposition of fibrous tissue inflammatory cell infiltration and fatty degeneration of hepatocytes.